Mapa fianaise
Allergies i gcéin: conas atá an bunús cruthaithe
12 foilseacháin, 3 acu trialanna agus 5 comhoibriúcháin. Déanann an leathanach seo cur síos ar chruth na litríochta sin seachas a comhoibriú a shíniú.
Cad atá sa litríocht seo
Tá an comhoibriú os cionn an litríochta phríomha anseo — athbhreithnithe agus anailísí méadaithe ag tarraingt ar líon measartha de staidéir bunúsacha. Déan cúram le conclúidí muiníneacha a chóireáil leis an gcúram a bhaineann le méid na sampla.
Is é an difríocht is tábhachtaí idir comhoibriú agus taighde príomha. Tógann anailís mhéadaithe trialanna agus is é an rud is gaire do fhreagra socraithe a tháirgeann réimse. Is léamh de ghrúpa amháin ar an ábhar céanna é athbhreithniú narraíochta agus d’fhéadfadh sé a bheith roghnach gan a bheith mímhacánta. Má tá siad á gcountáil le chéile, a dhéanann an chuid is mó de na comhoibriúcháin, cuireann sé in iúl go díreach an rud atá uait a fháil amach.
Conas a tógadh an leathanach seo
Tá gach rud thuas á ríomh ó na comhoibriúcháin a bhailigh an suíomh seo ó PubMed agus Crossref, ní scríobhadh le láimh. Nuair a finds an bailiúchán seachtainiúil páipéar nua ar an ábhar seo, athraíonn na comhoibriúcháin seo agus athraíonn an cur síos leo. Sin é an pointe: tosaíonn éileamh scríofa le láimh ar an neart atá ag bunús fianaise ag decaying an lá a scríobhadh é.
Tógtar cineál foilsitheachta mar a taifeadann an fhoinse é. Níl sé sin foirfe — tá laistigh de na comhoibriúcháin ag brath ar a chéile, agus d’fhéadfadh páipéar a comhoiriúnaithe mar “athbhreithniú” a bheith ina cheann córais — mar sin déan cúram le na bannaí mar thuar. Tá siad cruinn go leor chun litríocht trial a dhícheangal ó litríocht trácht, atá an difríocht a bhfuil tábhacht aici.
An obair is láidre ar an ábhar seo
Ordaithe de réir dearadh staidéir ar dtús, ansin nua. Tá an tacar iomlán liostaithe sna tagairtí thíos.
- Riosca anaflaise ar eitiltí tráchtála — Turner PJ, 2025, athbhreithniú sistemach
- Cé chomh coitianta atá freagairtí ailléirgeacha le linn eitiltí tráchtála? Athbhreithniú sistemach agus mheitheanaláis — Turner PJ, Mamula J, Laktabi J et al., 2023, mheitheanaláis
- Hoidrigh cúram craicinn i n-infreacha chun eczema agus ailléirge bia a chosc — Kelleher MM, Cro S, Cornelius V et al., 2021, mheitheanaláis
- Minicíocht, déine agus cúiseanna freagairtí ailléirgeacha neamhthráthúla ar bhia: athbhreithniú litríochta sistemach — Versluis A, Knulst AC, Kruizinga AG et al., 2015, athbhreithniú sistemach
- Treoirlínte EAACI maidir le h-ailléirge bia agus anaflaise: ag bainistiú othar le h-ailléirge bia sa phobal — Muraro A, Agache I, Clark A et al., 2014, treoir cliniciúil
- Éifeachtaí forlíonta prebiotics le linn toirchis agus lachtadh ar ghalar ailléirgeach na n-infreacha: trial rialaithe randoma — Palmer DJ, Cuthbert AR, Sullivan TR et al., 2025, trial rialaithe randoma
- Dieta diúltach aon-bhia i gcomparáid le dieta diúltach sé-bhia le haghaidh cóireáil eosinophilic oesophagitis: trial il-ionad, rialaithe randoma, oscailte00012-2) — Kliewer KL, Gonsalves N, Dellon ES et al., 2023, trial rialaithe randoma
- Mepolizumab do leanaí uirbeacha le asma eosinophilic atá i mbaol a chur faoi deara i SAM (MUPPITS-2): trial rialaithe randoma, dúbailte-dall, rialaithe le placebo, grúpa comhoiriúnach01198-9) — Jackson DJ, Bacharier LB, Gergen PJ et al., 2022, trial rialaithe randoma
- Tástáil Gníomhachtaithe Basophil: Ag droichead ailléirge agus oncológaíocht le haghaidh iarratais dhiagnóiseach, teiripeacha agus tuairiscíochta i AllergoOncology: Páipéar Seasamh EAACI — Pascal M, Chauhan J, Knol E et al., 2025, athbhreithniú
- Teoiric an bháire epitheil agus a ghalair gaolmhara — Sun N, Ogulur I, Mitamura Y et al., 2024, athbhreithniú
Cé mhéad taighde atá ann ar allerga i dtíortha eile?
An bhfuil níos mó taighde ag brath ar chonclúid níos láidre?
Cé chomh reatha is atá sé seo?
Cén fáth nach insíonn an leathanach seo dom an freagra?
References
Every citation below links to the original peer-reviewed record on PubMed or via DOI. Nothing here is a substitute for medical advice.
-
Risk of anaphylaxis on commercial flights Turner PJ · Current opinion in allergy and clinical immunology · 2025 · Systematic review DOIPubMed 40643054Full text
-
How Common Are Allergic Reactions During Commercial Flights? A Systematic Review and Meta-Analysis Turner PJ, Mamula J, Laktabi J, et al. · The journal of allergy and clinical immunology. In practice · 2023 · Meta-analysis DOIPubMed 37507067
-
Skin care interventions in infants for preventing eczema and food allergy Kelleher MM, Cro S, Cornelius V, et al. · The Cochrane database of systematic reviews · 2021 · Meta-analysis DOIPubMed 33545739Full text
-
Frequency, severity and causes of unexpected allergic reactions to food: a systematic literature review Versluis A, Knulst AC, Kruizinga AG, et al. · Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2015 · Systematic review DOIPubMed 24766413
-
EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community Muraro A, Agache I, Clark A, et al. · Allergy · 2014 · Clinical guideline DOIPubMed 24905609
-
Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergies Chinthrajah RS, Kulis M, Jones SM, et al. · The Journal of allergy and clinical immunology · 2026 · Randomised controlled trial DOIPubMed 41238005Full text
-
PrecISE-a biomarker-stratified adaptive trial of 5 interventions in severe asthma: Final protocol and the baseline cohort Denlinger LC, Israel E, Moore WC, et al. · The Journal of allergy and clinical immunology · 2026 · Randomised controlled trial DOIPubMed 41707916Full text
-
Early-life peanut oral immunotherapy associated with long-term ingestion and immunologic changes Dantzer JA, Virkud YV, Cox AL, et al. · The Journal of allergy and clinical immunology · 2026 · Randomised controlled trial DOIPubMed 42167657Full text
-
Effects of pregnancy and lactation prebiotics supplementation on infant allergic disease: A randomized controlled trial Palmer DJ, Cuthbert AR, Sullivan TR, et al. · The Journal of allergy and clinical immunology · 2025 · Randomised controlled trial DOIPubMed 39173718
-
A pediatric randomized, controlled trial of German cockroach subcutaneous immunotherapy Zoratti E, Wood R, Pomés A, et al. · The Journal of allergy and clinical immunology · 2024 · Randomised controlled trial DOIPubMed 38718950Full text
-
Double-Blind, Placebo-Controlled Study of E-B-FAHF-2 in Combination With Omalizumab-Facilitated Multiallergen Oral Immunotherapy Wang J, Wood RA, Raymond S, et al. · The journal of allergy and clinical immunology. In practice · 2023 · Randomised controlled trial DOIPubMed 37087097Full text
-
One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial Kliewer KL, Gonsalves N, Dellon ES, et al. · The lancet. Gastroenterology & hepatology · 2023 · Randomised controlled trial DOIPubMed 36863390Full text
-
Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial Jackson DJ, Bacharier LB, Gergen PJ, et al. · Lancet (London, England) · 2022 · Randomised controlled trial DOIPubMed 35964610Full text
-
Randomized, double-blind, placebo-controlled, food allergy challenge to olestra snacks Burks AW, Christie L, Althage KA, et al. · Regulatory toxicology and pharmacology : RTP · 2001 · Randomised controlled trial DOIPubMed 11603960
-
Basophil Activation Test: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An EAACI Position Paper Pascal M, Chauhan J, Knol E, et al. · Allergy · 2025 · Review DOIPubMed 40503572Full text
-
The epithelial barrier theory and its associated diseases Sun N, Ogulur I, Mitamura Y, et al. · Allergy · 2024 · Review DOIPubMed 39370939Full text
-
The restaurant syndromes Settipane GA · New England and regional allergy proceedings · 1987 · Review DOIPubMed 3302666
-
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study Ozonoff A, Jayavelu ND, Liu S, et al. · Nature communications · 2024 · Journal article DOIPubMed 38172101Full text
-
Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019 Shin YH, Hwang J, Kwon R, et al. · Allergy · 2023 · Journal article DOIPubMed 37431853Full text